AC Immune reported a net margin of -86.02% for the quarter ended Jun 2026. These financial ratios cover 44 quarters of results from Sep 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin | -343.47% | -1,874,700.00% | -3,312.95% | 21.59% | -1,389.09% | -1,922.12% | -1,622.43% | -1,688.82% | -4,252.37% | -1,322.70% | 12.40% | |||||||||||||||||||||||||||||||||
| EBIT Margin | -342.22% | -1,869,700.00% | -3,051.09% | 28.52% | -1,637.47% | -1,956.57% | -1,484.53% | -1,721.62% | -4,258.58% | -1,321.54% | 7.89% | |||||||||||||||||||||||||||||||||
| EBITDA Margin | -342.22% | -1,869,700.00% | -3,051.09% | 28.52% | -1,637.47% | -1,956.57% | -1,484.53% | -1,721.62% | -4,258.58% | -1,321.54% | 7.89% | |||||||||||||||||||||||||||||||||
| Operating Margin | -342.22% | -1,869,700.00% | -3,051.09% | 28.52% | -1,637.47% | -1,956.57% | -1,484.53% | -1,721.62% | -4,258.58% | -1,321.54% | 7.89% | |||||||||||||||||||||||||||||||||
| Net Margin | 0.00% | -23.00% | -3,347.89% | 0.00% | 3,078.23% | -1,919.19% | -0.02% | -1,703.94% | 16,567.84% | -0.01% | -86.02% | |||||||||||||||||||||||||||||||||
| FCF Margin | -341.03% | -1,736,600.00% | 10,639.74% | -54.83% | 529.82% | -1,918.79% | -1,212.02% | -1,983.17% | -4,918.05% | |||||||||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 226.51M | 252.53M | 269.28M | 240.05M | 218.97M | 202.93M | 187.94M | 178.32M | 167.82M | 183.99M | 198.87M | 227.16M | 272.29M | 272.75M | 249.18M | 232.27M | 222.15M | 203.76M | 184.24M | 182.89M | ||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 251.58M | |||||||||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | 0.13 | 0.12 | 0.13 | 0.14 | 0.02 | 0.02 | 0.02 | 0.12 | ||||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 112.06 | 131.72 | 122.27 | 157.61 | 174.84 | -0.02M | 181.14 | 631.33 | 594.85 | 136.19 | 557.44 | 616.50 | -220.27 | 620.60 | 358.70 | 387.76 | 351.43 | 342.71 | 227.51 | -19.56 | ||||||||||||||||||||||||
| Debt Ratio | ||||||||||||||||||||||||||||||||||||||||||||
| Times Interest Earned | 112.06 | 131.72 | 122.27 | 157.61 | 174.84 | -0.02M | 181.14 | 631.33 | 594.85 | 136.19 | 557.44 | 616.50 | -220.27 | 620.60 | 358.70 | 387.76 | 351.43 | 342.71 | 227.51 | -19.56 | ||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -2.01M | 0.01 | -17.06 | -15.14 | -1.59M | -0.71M | -0.86M | -1.11M | -1.17M | -8.80M | -14.24 | -15.56 | 5.41M | 6.79 | -8.89 | -0.80M | -14.51 | 4.56 | -1.46M | -14.72 | ||||||||||||||||||||||||
| Price to SalesP/S | 64.76 | 0.16M | 521.01 | 12.75 | 208.88 | 170.52 | 129.21 | 247.21 | 755.44 | 195.80 | 12.66 | |||||||||||||||||||||||||||||||||
| Price to BookP/B | 2.47 | 1.64 | 1.44 | 1.43 | 1.34 | 0.97 | 1.18 | 1.59 | 1.68 | 2.74 | 1.77 | 2.90 | 2.50 | 2.12 | 1.78 | 2.26 | 3.72 | 5.69 | 6.95 | 5.44 | ||||||||||||||||||||||||
| Enterprise Value | 277.30M | 379.37M | 145.69M | 141.31M | 118.31M | 111.85M | 81.68M | 143.66M | 147.83M | 332.59M | 173.53M | 202.15M | 192.72M | 82.20M | 25.81M | 50.27M | 154.59M | 205.10M | 184.28M | 146.80M | ||||||||||||||||||||||||
| EV to EBIT | -12.55 | -15.35 | -7.15 | -6.85 | -8.49 | -5.76 | -4.30 | -7.58 | -8.44 | -83.32 | -7.55 | -8.72 | 22.97 | -3.87 | -1.20 | -2.15 | -7.65 | -11.39 | -9.76 | 97.26 | ||||||||||||||||||||||||
| EV to EBITDA | -12.55 | -15.35 | -7.15 | -6.85 | -8.49 | -5.76 | -4.30 | -7.58 | -8.44 | -83.32 | -7.55 | -8.72 | 22.97 | -3.87 | -1.20 | -2.15 | -7.65 | -11.39 | -9.76 | 97.26 | ||||||||||||||||||||||||
| Market Capitalization | 482.70M | 413.22M | 333.92M | 301.36M | 263.79M | 170.59M | 195.67M | 247.10M | 238.32M | 495.99M | 293.63M | 395.80M | 374.97M | 271.11M | 187.77M | 203.83M | 290.19M | 319.47M | 279.79M | 242.15M | ||||||||||||||||||||||||
| Price to FCFP/FCF | -31.65 | -22.27 | -13.64 | -15.32 | -18.99 | -9.46 | -10.90 | -15.83 | -15.96 | -27.15 | 201.33 | 4.90 | -23.25 | 39.43 | -8.89 | -10.66 | -12.47 | -15.36 | ||||||||||||||||||||||||||
| EV to FCF | -18.18 | -20.45 | -5.95 | -7.18 | -8.52 | -6.20 | -4.55 | -9.20 | -9.90 | -18.21 | 118.98 | 2.50 | -11.95 | 11.95 | -1.22 | -2.63 | -6.64 | -9.86 | ||||||||||||||||||||||||||
| EV to CFO | -17.56 | -19.62 | -5.81 | -6.99 | -8.44 | -6.19 | -4.50 | -9.10 | -9.70 | -18.02 | 147.92 | 2.50 | -11.81 | 12.13 | -1.20 | -2.57 | -6.62 | -9.80 | ||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -2,455.56% | -3,815.00% | -8,409.42% | -342.22% | -1,869,700.00% | -3,051.09% | 28.52% | -1,637.47% | -1,956.57% | -1,484.53% | -1,721.62% | -4,258.58% | -1,321.54% | 7.89% | ||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -39.43% | -37.42% | -34.20% | -38.57% | -38.88% | -38.93% | -41.38% | -42.98% | -48.44% | -35.25% | -34.73% | -58.34% | -26.82% | -37.45% | -41.49% | -51.30% | -87.05% | -97.53% | -121.20% | -99.16% | ||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -34.58% | -31.61% | -30.35% | -33.82% | -35.55% | -36.58% | -38.71% | -39.87% | -44.24% | -32.68% | -31.01% | -29.99% | -16.39% | -21.01% | -23.28% | -25.16% | -38.09% | -41.50% | -44.67% | -29.71% |